William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
UCLA CTSI KL2 Resources
Presented by Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
Dr. Evans provides considerations in applying for a K99 Award. Provided by the UCLA Clinical and Translational Science Institute. More information at https://ctsi.ucla.edu/education/pages/edtools and https://ctsi.ucla.edu/education/pages/kprogram
Presenter:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Mitchell Wong, M.D. Ph.D.
Professor of Medicine
Executive Vice Chair for Research Training in the Department of Medicine.
Director of the CTSI KL2 Program,
Executive co-Director of the UCLA Specialty Training and Advanced Research (STAR) Program,
Co-Director of the UCLA NRSA Primary Care Fellowship
How to Anticipate and Plan for an R Grant Application (2020)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
UCLA CTSI K Workshop
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
Presentation date: February 09, 2017
Writing the NIH K Award
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
UCLA CTSI KL2 Resources
Presented by Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
Dr. Evans provides considerations in applying for a K99 Award. Provided by the UCLA Clinical and Translational Science Institute. More information at https://ctsi.ucla.edu/education/pages/edtools and https://ctsi.ucla.edu/education/pages/kprogram
Presenter:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Mitchell Wong, M.D. Ph.D.
Professor of Medicine
Executive Vice Chair for Research Training in the Department of Medicine.
Director of the CTSI KL2 Program,
Executive co-Director of the UCLA Specialty Training and Advanced Research (STAR) Program,
Co-Director of the UCLA NRSA Primary Care Fellowship
How to Anticipate and Plan for an R Grant Application (2020)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
UCLA CTSI K Workshop
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, UCLA CTSI Workforce Development
Presentation date: February 09, 2017
Writing the NIH K Award
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Navigating the NIH K Award Process (July 2015)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program (CTSI-ED)
UCLA CTSI KL2 Award, New NIH Guidelines on Rigor & TransparencyUCLA CTSI
Explanation of the UCLA CTSI KL2 Award and the new NIH guidelines on Rigor & Premise.
Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
Presentation date: February 09, 2017
UC Research Exchange (UC ReX) & Los Angeles Data Repository (LADR) UCLA CTSI
Learn more about the clinical data set tools, LADR and UC ReX available to UCLA CTSI, its partners and other UCs.
Marianne Zachariah
Administrator, Informatics Program
UCLA Clinical and Translational Science Institute
NIH Grant Proposals (SF 424): K08 - K23 Applications and Individual Career De...UCLA CTSI
Learn about NIH Grant Proposals (SF 424). Dr. Salusky discusses K08 - K23 applications and Individual Career Development Awards. Provided by the UCLA Clinical and Translational Science Institute. More information on K /CDA awards can be found at https://ctsi.ucla.edu/education/pages/edtools.
Presenter:
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Presentation date: February 09, 2017
UCLA CTSI K Workshop - February 4, 2016
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, Research Education, Training and Career Development Program
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016* (*updated Feb 1, 2017)
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Writing the NIH K Award (SF 424): K08-K23 Applications & Individual CDAsUCLA CTSI
Presented by:
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Presentation from: February 09, 2017
Navigating the NIH K Award Process (2021)UCLA CTSI
Navigating the NIH K Award Process
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Associate Director, UCLA CTSI
Leader, UCLA CTSI Workforce Development
UCLA CTSI K Workshop - February 4, 2016
Mariko Ishimori, MD
Associate Health Sciences Clinical Professor of Medicine
Cedars-Sinai Medical Center CTSI Associate Leader UCLA Clinical & Translational Science Institute
Isidro Salusky, MD “Writing the NIH K Award”
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
Grant Proposals (SF 424): K08-K23 Applications and Individual CDAsUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”UCLA CTSI
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
Navigating the NIH K Award Process (July 25, 2013)UCLA CTSI
Navigating the NIH K Award Process
Carol Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
A Tactical Approach to Writing Your Grant Application - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
A Tactical Approach to Writing Your Grant Application by William Parks, PhDUCLA CTSI
William Parks, PhD, speaks on the topic of "A Tactical Approach to Writing Your Grant Application" at the R Award Workshop on November 08, 2018 at UCLA.
Navigating the NIH K Award Process (July 2015)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program (CTSI-ED)
UCLA CTSI KL2 Award, New NIH Guidelines on Rigor & TransparencyUCLA CTSI
Explanation of the UCLA CTSI KL2 Award and the new NIH guidelines on Rigor & Premise.
Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
Presentation date: February 09, 2017
UC Research Exchange (UC ReX) & Los Angeles Data Repository (LADR) UCLA CTSI
Learn more about the clinical data set tools, LADR and UC ReX available to UCLA CTSI, its partners and other UCs.
Marianne Zachariah
Administrator, Informatics Program
UCLA Clinical and Translational Science Institute
NIH Grant Proposals (SF 424): K08 - K23 Applications and Individual Career De...UCLA CTSI
Learn about NIH Grant Proposals (SF 424). Dr. Salusky discusses K08 - K23 applications and Individual Career Development Awards. Provided by the UCLA Clinical and Translational Science Institute. More information on K /CDA awards can be found at https://ctsi.ucla.edu/education/pages/edtools.
Presenter:
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by:
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Presentation date: February 09, 2017
UCLA CTSI K Workshop - February 4, 2016
Learn to navigate through the possible career development awards (CDAs) available to you and which you should target.
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Leader, Research Education, Training and Career Development Program
K99/R00 Awards - Pathways to IndependenceUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016* (*updated Feb 1, 2017)
Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Director, Brain Research Institute
Writing the NIH K Award (SF 424): K08-K23 Applications & Individual CDAsUCLA CTSI
Presented by:
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Presentation from: February 09, 2017
Navigating the NIH K Award Process (2021)UCLA CTSI
Navigating the NIH K Award Process
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Associate Director, UCLA CTSI
Leader, UCLA CTSI Workforce Development
UCLA CTSI K Workshop - February 4, 2016
Mariko Ishimori, MD
Associate Health Sciences Clinical Professor of Medicine
Cedars-Sinai Medical Center CTSI Associate Leader UCLA Clinical & Translational Science Institute
Isidro Salusky, MD “Writing the NIH K Award”
Distinguished Professor of Pediatrics at UCLA
Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
Grant Proposals (SF 424): K08-K23 Applications and Individual CDAsUCLA CTSI
UCLA CTSI K Workshop - February 4, 2016
Isidro B. Salusky, MD
Distinguished Professor of Pediatrics at UCLA Chief, Division of Pediatric Nephrology
Director, Clinical Translational Research Center
Associate Dean of Clinical Research
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”UCLA CTSI
Carol Mangione, MD, MSPH “Navigating the NIH K Award Process”
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
Navigating the NIH K Award Process (July 25, 2013)UCLA CTSI
Navigating the NIH K Award Process
Carol Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, Research Education, Training and Career Development Program
A Tactical Approach to Writing Your Grant Application - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
A Tactical Approach to Writing Your Grant Application by William Parks, PhDUCLA CTSI
William Parks, PhD, speaks on the topic of "A Tactical Approach to Writing Your Grant Application" at the R Award Workshop on November 08, 2018 at UCLA.
A Tactical Approach to Writing Your Grant Application by William Parks, PhDUCLA CTSI
William Parks, PhD, speaks on the topic of "A Tactical Approach to Writing Your Grant Application" at the R Award Workshop on November 09, 2017 at UCLA.
Thinking about applying for a K award? Wondering how to put together the most competitive application?
NIH Research Career Development Awards (K awards) promote career development and provide support for senior postdoctoral fellows or faculty-level candidates. In this presentation, Dr. Sheila Lukehart leverages her many years of chairing K-award review committees at the NIH to provide practical tips and advice.
How to Anticipate and Plan for an R Grant Application - 2023UCLA CTSI
CTSI R Workshop: How to Anticipate and Plan for an R Grant Application.
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Leader, UCLA CTSI Workforce Development
How to Anticipate and Plan for an R Grant Application. (2022)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Leader, UCLA CTSI Workforce Development
This is about the proposal process. This can provide you a lot of things. brand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs. brand identitybrand image vs.
How to Craft the "Significance” & "Innovation" - 2023UCLA CTSI
CTSI R Workshop: How to Craft the "Significance” & "Innovation" Sections of a Grant Application
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
How to Anticipate and Plan for an R Grant ApplicationUCLA CTSI
UCLA CTSI K-to_R Workshop, October 29, 2015
Presenter:
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Associate Director, UCLA Clinical and Translational Science Institute
Program Leader, CTSI Research Education, Training and Career Development
What Next: When You are not Funded on the First Round - 2023UCLA CTSI
CTSI R Workshop: What Next: When You are not Funded on the First Round.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Write the “Specific Aims” Section - 2023UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application.
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
AssociateDirector, UCLA Specialty Training and Advanced Research (STAR) Program
How to Structure the “Approach” Section (Basic Science)UCLA CTSI
CTSI R Workshop: How to Structure the “Approach” Section of a Grant Application
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Craft the "Significance” & "Innovation" [Filler] - 2023UCLA CTSI
CTSI R Workshop: How to Craft the "Significance” & "Innovation" Sections of a Grant Application.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
A Tactical Approach to Writing Your Grant Application (HSR) - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application (HSR)
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
Associate Director, UCLA Specialty Training and Advanced Research (STAR) Program
How to Write the “Specific Aims” Section of a Grant Application (Basic Scienc...UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application (Basic Science
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
NIH Loan Repayment Program (LRP) Info Session - 9/26/23UCLA CTSI
The UCLA CTSI and DGSOM Office of Physician Scientist Career Development held this webinar to provide information on the NIH Loan Repayment Program (LRP). This funding is designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. The LRPs counteract financial pressure by repaying up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research.
Writing the NIH K Award – Research Plan
Presented by
Sumeet S. Chugh, MD
Price Professor and Associate Director, Smidt Heart Institute
Director, Division of Artificial Intelligence in Medicine
Cedars-Sinai Medical Center
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Co-Director, UCLA CTSI KL2 Program
Navigating the NIH K Award Process and Choosing Your Mentorship Team (2023)UCLA CTSI
Navigating the NIH K Award Process and Choosing Your Mentorship Team
Presented by
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Leader, UCLA CTSI Workforce Development
K Awards – Common Pitfalls and UCLA CTSI KL2 Resources (2023)UCLA CTSI
K Awards – Common Pitfalls and UCLA CTSI KL2 Resources
Presented by Elizabeta Nemeth, PhD
Professor of Medicine at UCLA
Director, UCLA Center for Iron Disorders
Co-Director, UCLA CTSI KL2 Program
Writing the NIH K Award – Candidate Information and Career Development Plan, ...UCLA CTSI
Writing the NIH K Award – Candidate Information and Career Development Plan,
How Reviewers Evaluate K Awards, and Common Critiques from NIH K Study Sections
Presented by O. Kenrik Duru, MD, MSHS
Professor of Medicine at UCLA
Investigator (Disparities), UCLA CTSI Special Populations
K99 Award: the NIH "Pathway to Independence"UCLA CTSI
UCLA CTSI K Workshop - July 28, 2022
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence" presented by Dr. Christopher Evans, PhD
The Indian economy is classified into different sectors to simplify the analysis and understanding of economic activities. For Class 10, it's essential to grasp the sectors of the Indian economy, understand their characteristics, and recognize their importance. This guide will provide detailed notes on the Sectors of the Indian Economy Class 10, using specific long-tail keywords to enhance comprehension.
For more information, visit-www.vavaclasses.com
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
How to Create Map Views in the Odoo 17 ERPCeline George
The map views are useful for providing a geographical representation of data. They allow users to visualize and analyze the data in a more intuitive manner.
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxEduSkills OECD
Andreas Schleicher presents at the OECD webinar ‘Digital devices in schools: detrimental distraction or secret to success?’ on 27 May 2024. The presentation was based on findings from PISA 2022 results and the webinar helped launch the PISA in Focus ‘Managing screen time: How to protect and equip students against distraction’ https://www.oecd-ilibrary.org/education/managing-screen-time_7c225af4-en and the OECD Education Policy Perspective ‘Students, digital devices and success’ can be found here - https://oe.cd/il/5yV
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
This is a presentation by Dada Robert in a Your Skill Boost masterclass organised by the Excellence Foundation for South Sudan (EFSS) on Saturday, the 25th and Sunday, the 26th of May 2024.
He discussed the concept of quality improvement, emphasizing its applicability to various aspects of life, including personal, project, and program improvements. He defined quality as doing the right thing at the right time in the right way to achieve the best possible results and discussed the concept of the "gap" between what we know and what we do, and how this gap represents the areas we need to improve. He explained the scientific approach to quality improvement, which involves systematic performance analysis, testing and learning, and implementing change ideas. He also highlighted the importance of client focus and a team approach to quality improvement.
Chapter 3 - Islamic Banking Products and Services.pptx
A Tactical Approach to Writing Your Grant Application (2020)
1. A Tactical (Practical) Approach to
Preparing Your Grant Application
William Parks, PhD
Department of Medicine
Cedars-Sinai and UCLA
2. Topics
• Emphasis on an NIH R01 Submission
• Preparation and Timelines
• Reviewers and Review Criteria
• Investigator Criterion – Preparing Your Biosketch
• Presentation Tips
3. My Central Recommendations
• Read other grants – both successful and unsuccessful
• Become familiar with the grant-submission process, rules, and deadlines
Both NIH and Institutional
• Give yourself plenty of time
• Get as much admin stuff – letters, budget, forms etc. – done or lined up early
• Get feedback from your mentor, committee, other faculty, your peers, and this
workshop
5. How to Submit your Application
1. Be familiar with NIH forms, etc.
2. Identify your group’s grant administrator
3. Tell this person that you plan to submit an R01 for Feb 2021
•Do this 2-3 months – if not longer – ahead of the due date
•Important: You are not the only one submitting a grant
4. Email your documents to your grant admin person
• Get the easy stuff done early (coming up)
5. Grant admin uploads components and builds application
6. Institution uploads to grants.gov.
6. Grant Preparation: NIH Things to do Well in Advance
• Familiarize yourself with NIH grants, forms, instructions, and due dates
• All grants: https://grants.nih.gov/grants/guide/parent_announcements.htm
• NIH Forms: http://grants.nih.gov/grants/forms.htm
• Page Limits: http://enhancing-peer-review.nih.gov/page_limits.html
• Due Dates: http://grants1.nih.gov/grants/funding/submissionschedule.htm
• Know what Institute to target and what they are in interested in
• RFA, Program announcements, etc. : http://www.grants.gov/
• By Institutes: http://www.nih.gov/icd/
• Know your competition
• RePORT (Research Portfolio Online Reporting Tools): http://report.nih.gov/
• Database of all NIH grants, success rates, and much more
Good video on some grant preparation tips:
http://www.youtube.com/watch?v=lAOGtr0pM6Q
7. Instructions
Download Research Instructions: Version F
Go here: https://grants.nih.gov/grants/how-to-apply-application-guide.html
Other Useful Sites
• How to apply videos: https://grants.nih.gov/grants/how-to-apply-application-guide/video/index.htm
• Portal to lots of info: https://www.nih.gov/grants-funding
• Fellowship kiosk: https://researchtraining.nih.gov/programs/career-development
9. Current Forms, PA, Review Criteria, etc. – A Useful Site
https://grants.nih.gov/grants/guide/parent_announcements.htm
All Grants:
10. NIH Dates for New (A0) R01s in 2021
Feb 5 Jan 29 June Sept Dec
June 5 (7) Jun 1 Oct Jan Apr
Oct 5 Sept 28 Feb May July
• OCGA* (UCLA) or ORA** (CS) submits your application to Grants.gov
• Your submission deadline to them is 5 (UCLA) or 3 (CS) days before
the NIH due date.
*Office of Contract and Grant Administration, **Office of Research Administration
NIH Due Dates
NIH
Submission
Due Date
UCLA
Due Date
Study
Section
Review
Council
Review
Funding
Begins
UCLA Due Dates
11. NIH Dates for Resubmitted (A1) R01s in 2021
Mar 5 Feb 26 June Sept Dec
Jul 5 (6) Jun 29 Oct Jan Apr
Nov 5 Oct 29 Feb May July
NIH
Submission
Due Date
UCLA
Due Date
Study
Section
Review
Council
Review
Funding
Begins
12. Timeline for a Feb 5, 2021 Deadline
Dec
2021
Funded!
Good
Score
Submit Reviewed
Think
Plan
Data
Write
Feedback
Re-write
Admin Stuff
Feb (Jan)
2021
Summer/Fall
2020
Oct to Jan
2020/21
Jun
2021
13. Timeline for a Feb 5, 2020 Deadline
Oct
2021
Feb
2022
Jul
2022
Funded!
Fair
Score
Resubmit
Re-
reviewed
Realistically a 2-year + Process
Good
Score
Submit
Think
Plan
Data
Write
Feedback
Re-write
Admin Stuff
Critique
2-3 weeks later
Reviewed
Feb (Jan)
2021
Summer/Fall
2020
Oct to Jan
2020/21
Jun
2021
14. Grant Preparation - Things to do Well in Advance
• Give yourself plenty of time
• Formulate your ideas and think
• Testable hypothesis that advances a field
• Present your ideas and aims to your colleagues
• Do this more than once
• Know the literature & be critical
• Issues and controversies
• What gaps will your work fill
• Generate preliminary data
• Support all hypotheses
• Confirms feasibility
• Publish
• The importance of this cannot be stressed enough
• Read successful applications!
• Seek advice
• Enlist collaborators, consultants
• Special reagents, techniques, advice
• Obtain letters
• Take care of the administrative stuff
• Budgets
• Human subjects, animals, biohazards, etc.
15. R01 Grant Sections
• Face Page
• Table of Contents
• Performance Site
• Project Information
• Project Description: Abstract
• Project Narrative: 2 sentences
• Facilities and Other Resources
• Equipment
• Key Personnel
• Biosketches
• Budget (all years)
• Budget Justification
• Cover Page Supplement
• Introduction
(resubmission only)
• Specific Aims
• Research Strategy
• Significance, Premise
• Innovation
• Approach
• Preliminary Data
• Research Plan
• Protection of Human Subjects
• Women & Minorities
• Planned Enrollment Table
• Children
• Vertebrate Animals
• References Cited
• Multiple PI Plan
• Letters of Support
• Resource Sharing
• Authentication of Key
Biological and/or Chemical
Resources
• Checklist
16. R01 Grant Sections You Prepare
• Face Page
• Table of Contents
• Performance Site
• Project Information
• Project Description: Abstract
• Project Narrative: 2 sentences
• Facilities and Other Resources
• Equipment
• Key Personnel
• Biosketches
• Budget (all years)
• Budget Justification
• Cover Page Supplement
• Introduction
(resubmission only)
• Specific Aims
• Research Strategy
• Significance, Premise
• Innovation
• Approach
• Preliminary Data
• Research Plan
• Protection of Human Subjects
• Women & Minorities
• Planned Enrollment Table
• Children
• Vertebrate Animals
• References Cited
• Multiple PI Plan
• Letters of Support
• Resource Sharing
• Authentication of Key
Biological and/or Chemical
Resources
• Checklist
17. R01 Grant Sections Easy or Boilerplate
• Face Page
• Table of Contents
• Performance Site
• Project Information
• Project Description: Abstract
• Project Narrative: 2 sentences
• Facilities and Other Resources
• Equipment
• Key Personnel
• Biosketches
• Budget (all years)
• Budget Justification
• Cover Page Supplement
• Introduction
(resubmission only)
• Specific Aims
• Research Strategy
• Significance, Premise
• Innovation
• Approach
• Preliminary Data
• Research Plan
• Protection of Human Subjects
• Women & Minorities
• Planned Enrollment Table
• Children
• Vertebrate Animals
• References Cited
• Multiple PI Plan
• Letters of Support
• Resource Sharing
• Authentication of Key
Biological and/or Chemical
Resources
• Checklist
20. All NIH Institutes Review Grant Applications
Office of the Director
National Institute
on Alcohol Abuse
and Alcoholism
National Institute
of Arthritis and
Musculoskeletal
and Skin Diseases
National Cancer
Institute
National Institute
of Diabetes and
Digestive and
Kidney Diseases
National Institute
of Dental and
Craniofacial
Research
National Institute
on Drug Abuse
National Institute
of Environmental
Health Sciences
National Institute
on Aging
National Institute
of Child Health
and Human
Development
National Institute on
Deafness and Other
Communication
Disorders
National Eye
Institute
National Human
Genome Research
Institute
National Heart,
Lung, and Blood
Institute
National Institute
of Mental Health
National Institute
of Neurological
Disorders and
Stroke
National Institute
of General
Medical Sciences
National Institute
of Nursing Research
National Library
of Medicine
Center for
Information
Technology
Center for
Scientific Review
National Center
for Complementary
and Alternative
Medicine
National Institute
of Allergy and
Infectious Diseases
Fogarty
International
Center
National Center
for Research
Resources
Clinical Center
National Institute of
Biomedical Imaging
and Bioengineering
National Center on
Minority Health and
Health Disparities
NIH Institutes
http://www.nih.gov/icd/
No funding
authority
But CSR does the
bulk of reviews
21. The Fate and Evaluation of Your Proposal
Pretty dull and needlessly long video of this topic
http://www.youtube.com/watch?v=DuuAGROm_1Q&feature=relmfu
Your can influence this process
Institute Assignment
Study Section
Assignment
You ➜ ➜ ➜ CSR ➜ ➜ Reviewers ➜ Back to You
• Suggest Institute assignment
• Suggest Study Section
• Identify conflicts
• Identify areas of needed expertise
• Special situations
• Do not recommend specific reviewers
Cover Letter
(optional)
Project
Information
OCGA
ORA
Grant
Admin
22. Who Do You Call?
• Institute based
• Before submission
• After initial (study section)
review
• Has influence on funding
• Tracks progress
Program Officer (PO) Scientific Review Officer (SRO)
• CSR (mostly) or institute based
• During initial review stage
• Has no influence on funding
PO SRO
Submit
to NIH
Grant Preparation
Resubmit
to NIH
2nd
Review
Funded
1st
Review
PO
23. CSR and Study Sections
• CSR: Center for Scientific Review
• 70-80,000 applications per year
• Study Sections (>220): Organ, disease,
scientific-based expertise
• ~24 members per study section, essentially all from academia
• 40-90 applications per Study Section meeting
• 3 reviewers per applications
• 10-12 applications per member
• Information at the CSR web site
• Study section scope and policies
• Roster of reviewers
• Schedules
• Study sections are advisory - they do not fund applications.
24. Review Process - Before the Meeting
• Applications available about 6 weeks before meeting (all via web)
• Scores and critiques are uploaded 1 week before study section
• Each criterion is given a score: 1, 2, 3…9 (outstanding to really bad)
• These are not discussed at the Study Section
• But they are included in the Summary Statement you will get
• Each reviewer gives each application an overall Impact Score (1-9)
• Impact Score is not the mean of the criteria scores
• Impact score is key and the only score discussed
• Initial scores and critiques become available to all committee members
25. Scored Review Criteria
Scored Criteria for
R-series Proposals
• Significance
• Investigator
• Approach
• Innovation
• Environment
Overall
Impact
Overall Impact or
Criterion Strength
Score Descriptor
High
1 Exceptional
2 Outstanding
3 Excellent
Moderate
4 Very Good
5 Good
6 Satisfactory
Low
7 Fair
8 Marginal
9 Poor
!
• Criterion Score
• Whole numbers: 1-9
• 1 (exceptional); 9 (well let’s just hope you never get a 9)
• Given by reviewers but not discussed at study section
• Provided in Summary Statement of all applications
• Overall Impact Score
• Not the mean of the criteria scores
• Different criteria are weighted by each reviewer
• Final Impact Score, Percentile
• Mean of all scores x 10 ➤ 10 – 90
• Percentiled against R01s applications across 3 meetings
26. Where and When Do Reviewers Review Grant Applications?
• At the last minute - and thus a bunch in one sitting
• Hence, reviewers can be stressed, anxious, and
not terribly sympathetic
• Do not make the reviewer read
papers or go to the internet
• Do not make the reviewer think!
• Do not tick off the reviewers!
Don’t let the reviewer become…
or Bored
Baffled,
Bitter,
27. The Review Process - at the Meeting
Good video of a mock Study Section
https://www.youtube.com/watch?v=fBDxI6l4dOA
• Review Grants - random order
• Assigned reviewers state their scores: 1, 2, 3…9
• 1˚ reviewer, 2˚, 3˚, then open for discussion
• All members vote (score)
• Final Impact Score = (Mean of all scores) x 10
• Expressed as a % of all scores over 3 meetings
• Lower 50% are not discussed
• 15-20 min per application
• Begin at 8 am EST (i.e., 5 am PST)
• Cramped room full of laptops and several
jet-lagged reviewers
• Now virtual
29. Current Forms, PA, Review Criteria, etc. – A Useful Site
https://grants.nih.gov/grants/guide/parent_announcements.htm
All Grants:
Read these sections
R01
30. Scored Review Criteria
Individual Training
F-series Grants
• Candidate
• Career development plan
Career goals and objectives
Plan to provide mentoring
• Research Plan
• Mentor(s), consultants, collaborators
• Environment &
Institutional commitment
Career Development
K-series Grants
Investigator Initiated
R-series Grants
• Significance*
• Investigator*
• Approach*
• Innovation
• Environment
Focus on training potential Focus on the science and you
*Most important
• Candidate
• Training Potential
• Research Plan
• Mentor(s), consultants, collaborators
• Environment &
Institutional commitment
31. Review Criteria for R Applications
• Overall Impact
• Scored Criteria
• Significance
• Investigator
• Innovation
• Approach
• Environment
• Additional Review Criteria
• Human Subjects, Inclusion
• Vertebrate Animals
• Biohazards
• Resubmission
• Additional Review Considerations
• Select Agents
• Resource Sharing Plan
• Authentication of Key Biological…
• Budget
Affects
Impact
Score
Yes
Yes
No
Affects
Criterion
Scores
No
Yes
No
32. R01 Grant Sections That Reviewers Care About
• Face Page
• Table of Contents
• Performance Site
• Project Information
• Project Description: Abstract
• Project Narrative: 2 sentences
• Facilities and Other Resources
• Equipment
• Key Personnel
• Biosketches
• Budget (all years)
• Budget Justification
• Cover Page Supplement
• Introduction
(resubmission only)
• Specific Aims
• Research Strategy
• Significance, Premise
• Innovation
• Approach
• Preliminary Data
• Research Plan
• Protection of Human Subjects
• Women & Minorities
• Planned Enrollment Table
• Children
• Vertebrate Animals
• References Cited
• Multiple PI Plan
• Letters of Support
• Resource Sharing
• Authentication of Key
Biological and/or Chemical
Resources
• Checklist
33. R01 Grant Sections That Reviewers Really Care About
• Face Page
• Table of Contents
• Performance Site
• Project Information
• Project Description: Abstract
• Project Narrative: 2 sentences
• Facilities and Other Resources
• Equipment
• Key Personnel
• Biosketches
• Budget (all years)
• Budget Justification
• Cover Page Supplement
• Introduction
(resubmission only)
• Specific Aims
• Research Strategy
• Significance, Premise
• Innovation
• Approach
• Preliminary Data
• Research Plan
• Protection of Human Subjects
• Women & Minorities
• Planned Enrollment Table
• Children
• Vertebrate Animals
• References Cited
• Multiple PI Plan
• Letters of Support
• Resource Sharing
• Authentication of Key
Biological and/or Chemical
Resources
• Checklist
34. Biosketch
• Important to show what you have done
• Keep the Personal Statement succinct (300 words)
• Education and Training only
• Month and year
OMB No. 0925-0001 and 0925-0002 (Rev. 03/2020 Approved Through 02/28/2023)
BIOGRAPHICAL SKETCH
Provide the following information for the Senior/key personnel and other significant contributors.
Follow this format for each person. DO NOT EXCEED FIVE PAGES.
NAME:
eRA COMMONS USER NAME (credential, e.g., agency login):
POSITION TITLE:
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing,
include postdoctoral training and residency training if applicable. Add/delete rows as necessary.)
INSTITUTION AND LOCATION
DEGREE
(if applicable)
Completion
Date
MM/YYYY
FIELD OF STUDY
A.Personal Statement
“Briefly describe why you are well-suited for your role(s) in the project
described in this application...”
B.Positions and Honors
Positions and Employment
Past to current.
Do not duplicate what’s above under Education.
Other Experience and Profession Memberships
Societies, committees, etc.
Honors
Nothing from high school.
C.Contribution to Science
• Experience, training and career goals
• 1st person
• 4 publications, preprints and/or research products**
• Gaps in training
• No figures, graphs, tables
FAQs: https://grants.nih.gov/grants/policy/faq_biosketches.htm#
Forms: https://grants.nih.gov/grants/forms/biosketch.htm
35. Biosketch
OMB No. 0925-0001 and 0925-0002 (Rev. 03/2020 Approved Through 02/28/2023)
BIOGRAPHICAL SKETCH
Provide the following information for the Senior/key personnel and other significant contributors.
Follow this format for each person. DO NOT EXCEED FIVE PAGES.
NAME:
eRA COMMONS USER NAME (credential, e.g., agency login):
POSITION TITLE:
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing,
include postdoctoral training and residency training if applicable. Add/delete rows as necessary.)
INSTITUTION AND LOCATION
DEGREE
(if applicable)
Completion
Date
MM/YYYY
FIELD OF STUDY
A. Personal Statement
This is what 300 words looks like. This is what 300 words looks like. This is what 300 words looks like. This is
what 300 words looks like. This is what 300 words looks like. This is what 300 words looks like. This is what
300 words looks like. This is what 300 words looks like. This is what 300 words looks like. This is what 300
words looks like. This is what 300 words looks like. This is what 300 words looks like. This is what 300 words
looks like. This is what 300 words looks like. This is what 300 words looks like. This is what 300 words looks
like. This is what 300 words looks like. This is what 300 words looks like. This is what 300 words looks like.
This is what 300 words looks like. This is what 300 words looks like. This is what 300 words looks like. This is
what 300 words looks like. This is what 300 words looks like. This is what 300 words looks like. This is what
300 words looks like. This is what 300 words looks like. This is what 300 words looks like. This is what 300
words looks like. This is what 300 words looks like. This is what 300 words looks like. This is what 300 words
looks like. This is what 300 words looks like. This is what 300 words looks like. This is what 300 words looks
like. This is what 300 words looks like. This is what 300 words looks like. This is what 300 words looks like.
This is what 300 words looks like. This is what 300 words looks like. This is what 300 words looks like. This is
what 300 words looks like. This is what 300 words looks like.
**Research Products
• Audio or video products
• Meeting abstracts, posters, or other presentations
• Patents
• Data and research materials
• Databases
• Educational aids or curricula
• Instruments or equipment
• Models; protocols; and software or netware.
36. Biosketch
• Briefly describe up to five of your most
significant contributions to science
• 1-4 publications and/or preprints*
• Do not need to list 5 areas.
• DO NOT include abstracts as Publications
• Up-to-date (no “In press…2018”)
• Full citations: all authors, accepted journal abbreviations
• Consistent format*
• Name changed? Let us know
• Must match what we see at PubMed
• Some leeway is OK
• OK to include manuscripts submitted and in preparation
• OK to add a section for abstracts, other products
(e.g., Presentations)
* Your name in the order of authors
Year published
Journal
C. Contributions to Science
1. Discovered DNA. Blah blah blah ––––––––––––––––––––––––––––––––––––––––
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
––––––––––––––––––––––––––––––––––blah.
a. Pub
b. Pub
c. Pub
d. Pub
2. Cured Cancer. Blah blah blah ––––––––––––––––––––––––––––––––––––––––––
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
––––––––––––––––––––––––––––––––blah.
e. Pub
f. Pub
g. Pub
h. Pub
3. Other Big Thing.
4. Yet Another Fascinating Accomplishment.
5. Abstracts/Presentations.
Complete List of Published Work:
http://www.ncbi.nlm.nih.gov/sites/myncbi/your.name/bibliography/
D. Research Support
Ongoing Research Support
Grant NumberPI’s Last Name (PI)Start-End Date
Grant/project Title
Brief description of project (1 sentence will do)
Role: Your Role
Completed Research Support
*Reporting Preprints and Other Interim Research Products
37. Review Criteria - Investigator
• Early Stage Investigators (ESI)
• More emphasis on experience and training
• Publications are important but not critically so
• ESIs get a bit of break with productivity
– but just a bit
• Quality and relevance of publications
are important criteria
• Reality: Numbers and quality do matter.
Your competition may have more.
• Pay line handicap varies by institute
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-101.html
https://grants.nih.gov/policy/early-investigators/index.htm
https://www.niaid.nih.gov/grants-contracts/new-investigators
• New Investigator
• Never had an RPG
• No age limit
• Few institutes support this
• NIAID
• Established Investigators
• Track record
• Productivity
• Accomplishments
• Early Established Investigators (EEI)
• Within 10 yr of 1st R01
• Only 1 grant and at risk of losing it
38. ESI Handicap ➞ Equal Success Rates
New
Established
No difference by gender
39. Review Criteria - Investigator
• Not a review criterion
• Does not affect scoring
• Cannot even be discussed
NIH/CSR Rules
Independence
Reality
• However, it is in the reviewer’s mind
• If you remain associated with your mentor, include a letter
from him/her confirming your independence
• My Advice: Do not include your mentor as key personnel
• Do not say your lab space is in their lab space
• Get a letter from your chair indicating commitment to you
41. Formatting
• For all sections you prepare
• MS Word.docx
• 0.5-in margins
• 11 pt Arial
• No header or footer
• Submit to grant admin as PDFs
Guide: https://grants.nih.gov/grants/how-to-apply-application-guide.html#format
Fonts: https://grants.nih.gov/grants/how-to-apply-application-guide/format-and-write/format-attachments.htm
Page Limits: https://grants.nih.gov/grants/how-to-apply-application-guide/format-and-write/page-limits.htm
• Facilities and Other Resources
• Budget Justification
• Introduction (resubmission only)
• Specific Aims
• Research Strategy
• Human Subjects pages
• Vertebrate Animals
• References Cited
• Multiple PI Plan
• Resource Sharing
• Authentication of Key Biological and/or
Chemical Resources
42. Presentation and Style
• Paragraphs and spaces
• Don’t make it look dense or cluttered
• Flow
• Logical transitions from sentence to sentence, paragraph to paragraph
• Do the work for your reader
• Use some system (bold, numbers) to outline sections and
subsections
•Again, read successful applications
• Zero tolerance for tpyos
• Avoid excessive use of abbreviations
• Avoid vague terms: e.g., ‘affects’, ‘influences’
• Avoid pleonasms: “…has been shown to…”
• Clean, concise English
• Active voice is better than the passive voice